The present invention relates to parenteral formulations for certain long chain saturated and monounsaturated fatty acid derivatives of 1-&bgr；-D-arabinofuranosylcytosine (cytarabine). In particular, the present invention relates to a parenteral pharmaceutical composition and a method of the preparation thereof, in order to accommodate therapeutically effective doses of the said derivatives ameliorating compliance in treatment of cancer.
